Starfill dermal fillers are obtained using the "Zero Endotoxin and BDDE Entire Process" (SOAP) technology, which ensures minimal endotoxin and residual BDDE levels.
The product has a high HA cross-linking degree, excellent viscoelasticity and cohesion parameter values. Low toxin and cross-linking agent levels ensure the high safety of the product while minimizing the risk of post-injection edema, allergic reactions and other side effects.
Needle 27G x 2ea
1 syringe × 1.1 ml
